These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11741346)

  • 1. IL-6 polymorphism, anti-IL-6 therapy and animal models of multiple myeloma.
    Jeffery R; Mitchison NA
    Cytokine; 2001 Nov; 16(3):87. PubMed ID: 11741346
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma].
    Iakupova EV; Grinchuk OV; Kalimullina DKh; Bakirov BA; Galimova RR; Makarova OV; Khusnutdinova EK; Viktorova TV
    Mol Biol (Mosk); 2003; 37(3):420-4. PubMed ID: 12815949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma.
    Mazur G; Bogunia-Kubik K; Wróbel T; Karabon L; Polak M; Kuliczkowski K; Lange A
    Immunol Lett; 2005 Jan; 96(2):241-6. PubMed ID: 15585329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
    Cozen W; Gebregziabher M; Conti DV; Van Den Berg DJ; Coetzee GA; Wang SS; Rothman N; Bernstein L; Hartge P; Morhbacher A; Coetzee SG; Salam MT; Wang W; Zadnick J; Ingles SA
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2285-91. PubMed ID: 17119059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis.
    Hodge DR; Xiao W; Peng B; Cherry JC; Munroe DJ; Farrar WL
    Cancer Res; 2005 Jul; 65(14):6255-63. PubMed ID: 16024627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of thalidomide on interleukin-6 and its transmission in multiple myeloma patients].
    Li J; Luo S; Hong W; Zhou Z; Zou W
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):254-6. PubMed ID: 12515619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
    Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis.
    Schmidt S; Papassotiropoulos A; Sotgiu S; Kölsch H; Arru G; Fois ML; Haase CG; Schmitz S; König N; Harzheim M; Heun R; Klockgether T
    J Neurol; 2003 May; 250(5):607-11. PubMed ID: 12736743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
    Bittar MN; Carey JA; Barnard J; Fildes JE; Pravica V; Yonan N; Hutchinson IV
    Heart Surg Forum; 2005; 8(3):E140-5; discussion E145. PubMed ID: 16183563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells.
    Gerlo S; Haegeman G; Vanden Berghe W
    Cell Signal; 2008 Aug; 20(8):1489-96. PubMed ID: 18502099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of an interleukin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing.
    Wieser F; Fabjani G; Tempfer C; Schneeberger C; Sator M; Huber J; Wenzl R
    J Soc Gynecol Investig; 2003 Jan; 10(1):32-6. PubMed ID: 12517591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study.
    Licastro F; Chiappelli M; Caldarera CM; Tampieri C; Nanni S; Gallina M; Branzi A
    Mech Ageing Dev; 2004 Aug; 125(8):575-9. PubMed ID: 15336915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort.
    Sekuri C; Cam FS; Sagcan A; Ercan E; Tengiz I; Alioglu E; Berdeli A
    Coron Artery Dis; 2007 Aug; 18(5):333-7. PubMed ID: 17627181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
    Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
    Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines.
    Verdelli D; Mattioli M; Fabris S; Nobili L; Intini D; Guerneri S; Todoerti K; Zanella A; Deliliers GL; Lombardi L; Neri A
    Haematologica; 2005 Nov; 90(11):1541-8. PubMed ID: 16266902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
    Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
    Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum level and genotype of interleukin-6 in patients with esophageal cancer].
    Tang RG; Wei YS; Chen HM; Fang WZ; Long XK; Yuan XH
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1126-8. PubMed ID: 17672997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and interleukin-6 promoter polymorphism (-174) G > C in patients with spontaneous venous thromboembolism.
    Vormittag R; Hsieh K; Kaider A; Minar E; Bialonczyk C; Hirschl M; Mannhalter C; Pabinger I
    Thromb Haemost; 2006 May; 95(5):802-6. PubMed ID: 16676071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.